4.7 Article

Trabecular Bone Score Significantly Influences Treatment Decisions in Secondary Osteoporosis

Related references

Note: Only part of the references are listed.
Editorial Material Biochemistry & Molecular Biology

Secondary Osteoporosis: A Still Neglected Condition

Vittoria Favero et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Endocrinology & Metabolism

Bone quality in endocrine diseases: determinants and clinical relevance

L. Cianferotti et al.

Summary: Endocrine diseases can lead to osteoporosis and fractures, but traditional bone density measurement methods may not accurately capture skeletal alterations caused by endocrine disorders. Therefore, it is important to use new techniques to assess bone quality for the diagnosis and prediction of skeletal fragility and fracture risk.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Biotechnology & Applied Microbiology

2D-3D reconstruction of the proximal femur from DXA scans: Evaluation of the 3D-Shaper software

Alice Dudle et al.

Summary: Osteoporosis is currently diagnosed based on 2D DXA scans, but this method does not consider the 3D bone geometry and density distribution. QCT scans combined with FE analysis can provide improved femoral strength predictions, but high radiation dose and cost limit its usage. The 3D-Shaper software reconstructs the 3D shape and density distribution of the femur from 2D DXA scans, which could provide a more accurate estimation of femoral strength.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2023)

Review Rheumatology

Bone and primary hyperparathyroidism

Catherine Cormier et al.

Summary: Primary hyperparathyroidism is a disease characterized by excessive secretion of parathyroid hormone leading to hypercalcemia, with diagnosis based on high levels of calcium and parathyroid hormone. Surgery is the primary treatment option to prevent complications and fractures.

JOINT BONE SPINE (2022)

Article Clinical Neurology

Prevalence of Poor Bone Quality in Patients Undergoing Spine Surgery: A Comprehensive Approach

Ricardo Diaz-Romero Paz et al.

Summary: The study found that poor bone quality and low levels of vitamin D are common among patients over 50 years old undergoing spine surgery. Pain levels are associated with low bone mineral density levels, and TBS and FRAX can be valuable tools for identifying impaired bone quality cases.

GLOBAL SPINE JOURNAL (2022)

Article Rheumatology

Glucocorticoid-induced osteoporosis-Focus treatment (part 1)

Peter Oelzner et al.

Summary: GC-induced osteoporosis is a significant comorbidity in inflammatory rheumatic diseases, with a fracture prevalence of 30-50%. The currently available methods of osteodensitometry are not effective in assessing the fracture risk during long-term GC treatment. Guidelines recommend baseline osteological diagnosis and various measures to prevent and treat osteoporosis.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2022)

Article Rheumatology

Glucocorticoid-induced osteoporosis-Focus treatment (part 2)

Peter Oelzner et al.

Summary: Approved substances for the treatment of glucocorticoid-induced osteoporosis include oral and intravenous bisphosphonates, RANKL antibody, and teriparatide. All these substances reduce vertebral fractures, with teriparatide being more effective than bisphosphonates. The severity of osteoporosis, treatment approach, and contraindications are important factors for selecting the appropriate treatment substance.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2022)

Review Urology & Nephrology

Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review

Charles Ginsberg et al.

Summary: Osteoporosis and fractures are common in persons with advanced CKD and on maintenance dialysis. Imaging, biomarkers, and bone biopsy can help identify high-risk patients and target bone turnover abnormalities. Data on osteoporosis drugs in advanced CKD patients are limited.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

Article Endocrinology & Metabolism

Bone Analysis Using Trabecular Bone Score and Dual-Energy X-Ray Absorptiometry-Based 3-Dimensional Modeling in Postmenopausal Women With Primary Hyperparathyroidism

Rosa Arboiro-Pinel et al.

Summary: This study evaluated bone microarchitectural differences using DXA, TBS, and 3D-DXA between postmenopausal women diagnosed with PHPT and healthy postmenopausal controls. The results showed significant involvement of the trabecular and cortical compartments in PM-PHPT patients.

ENDOCRINE PRACTICE (2022)

Article Nutrition & Dietetics

The Potential Impact of Inducing a Restriction in Reimbursement Criteria on Vitamin D Supplementation in Osteoporotic Patients with or without Fractures

Luca Degli Esposti et al.

Summary: A retrospective analysis in Italy found that the restriction of reimbursement criteria for vitamin D outside of osteoporosis led to an increased risk of discontinuation of vitamin D supplementation in osteoporosis patients. This study highlights the importance of proper interpretation and implementation of reimbursement criteria to ensure adequate treatment for osteoporosis patients and reduce the risk of negative outcomes.

NUTRIENTS (2022)

Article Rheumatology

Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease

Edgar Wiebe et al.

Summary: The study examined the impact of variables on osteoporosis (OP) in patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs) treated with glucocorticoids (GCs). The results showed that GC doses of <= 5 mg/day were not associated with a reduction in bone mineral density (BMD), which may be due to the anti-inflammatory effect of GCs. However, in patients with rheumatoid arthritis (RA), GC doses of >7.5 mg/day were negatively associated with BMD, but only in those with moderate to high disease activity.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Environmental Sciences

The Phenotype of Bone Turnover in Patients with Fragility Hip Fracture: Experience in a Fracture Liaison Service Population

Carla Caffarelli et al.

Summary: This study found that patients with hip fractures often have vitamin D deficiency, elevated PTH levels, and a history of previous fragility fractures. Assessment of bone turnover markers and comorbidity index can help better identify the risk of hip fractures.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Rheumatology

The global burden of fragility fractures e what are the differences, and where are the gaps

Paul James Mitchell et al.

Summary: This review discusses the current burden, risk factors, acute management, and care gaps in fragility fractures in different settings. It provides a summary of global, regional, and national initiatives to improve care quality and proposes a research agenda. Systematic approaches to improve acute care, rehabilitation, and prevention of fragility fractures are crucial for high-, middle-, and low-income countries worldwide.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2022)

Article Rheumatology

Risk factors for osteoporosis and fractures in rheumatoid arthritis

Rahaf Baker et al.

Summary: People with rheumatoid arthritis (RA) are at increased risk of osteoporosis and fractures due to both disease-specific factors and those that affect the general population. Disease-specific factors include auto-antibodies, systemic inflammation, and joint damage, while factors affecting the general population such as smoking, calcium and vitamin D deficiency, and hypogonadism may have a higher prevalence in RA. Chronic exposure to glucocorticoids also contributes to reduced bone density and increased fracture risk.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2022)

Article Endocrinology & Metabolism

Trabecular bone score in the hip: a new method to examine hip bone microarchitecture-a feasibility study

Nami Safai Haeri et al.

Summary: Our study suggests that assessing hip microarchitecture with DXA-derived bone texture score may complement bone mineral density in predicting fractures and guiding pharmacological management for older adults in long-term care facilities.

ARCHIVES OF OSTEOPOROSIS (2022)

Review Medicine, General & Internal

A Mini Review on Osteoporosis: From Biology to Pharmacological Management of Bone Loss

Kok-Yong Chin et al.

Summary: This review provides an overview of osteoporosis, including its biology, epidemiology, and clinical aspects, serving as an updated reference for readers to understand the basics of the disease and take preventive and management actions.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Endocrinology & Metabolism

Trabecular bone score as an additional therapeutic decision tool in osteoporosis and osteopenia

Atiporn Therdyothin et al.

Summary: The role of trabecular bone score (TBS) was evaluated in postmenopausal women with osteopenia, and it was found that TBS can help capture women with low bone mass at high risk of fractures. It is recommended to evaluate TBS in osteopenic women without fractures to aid therapeutic decision-making.

OSTEOPOROSIS AND SARCOPENIA (2022)

Article

Application of the Trabecular Bone Score in Clinical Practice

Sung Hye Kong et al.

Journal of Bone Metabolism (2021)

Article Multidisciplinary Sciences

Analyses of the relationship between hyperuricemia and osteoporosis

Jung Woo Lee et al.

Summary: The study found an association between hyperuricemia and a decreased risk of osteoporosis, especially among individuals with a history of hypertension, diabetes mellitus, or hyperlipidemia.

SCIENTIFIC REPORTS (2021)

Article Obstetrics & Gynecology

Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society

Jennifer Blake et al.

Summary: This article reviews evidence on osteoporosis screening, prevention, diagnosis, and management over the past decade, and updates the position statement of The North American Menopause Society on managing osteoporosis in postmenopausal women. The focus is on assessing bone density and risk factors in postmenopausal women, whether through lifestyle and dietary adjustments or pharmacologic therapy, to prevent fractures and maintain skeletal health.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2021)

Review Endocrinology & Metabolism

DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis

Enisa Shevroja et al.

Summary: This review focuses on the role of trabecular bone score (TBS) in assessing bone health in endocrine disorders, emphasizing its ability to predict fractures independently of bone mineral density (BMD).

ENDOCRINE (2021)

Review Rheumatology

The utility and limitations of using trabecular bone score with FRAX

Patrick Martineau et al.

CURRENT OPINION IN RHEUMATOLOGY (2018)

Article Endocrinology & Metabolism

Is trabecular bone score less affected by degenerative-changes at the spine than lumbar spine BMD?

Kara B. Anderson et al.

ARCHIVES OF OSTEOPOROSIS (2018)

Review Endocrinology & Metabolism

DXA-Based Measurements in Diabetes: Can They Predict Fracture Risk?

G. Isanne Schacter et al.

CALCIFIED TISSUE INTERNATIONAL (2017)

Article Endocrinology & Metabolism

The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort

I. Padlina et al.

OSTEOPOROSIS INTERNATIONAL (2017)

Article Endocrinology & Metabolism

Trabecular bone score (TBS): Method and applications

P. Martineau et al.

Article Endocrinology & Metabolism

A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX

Eugene V. McCloskey et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2016)

Article Endocrinology & Metabolism

Bone status in glucocorticoid-treated men and women

E. S. Leib et al.

OSTEOPOROSIS INTERNATIONAL (2016)

Article Endocrinology & Metabolism

The Association Between Trabecular Bone Score and Lumbar Spine Volumetric BMD Is Attenuated Among Older Men With High Body Mass Index

Lisa Langsetmo et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2016)

Review Endocrinology & Metabolism

Secondary osteoporosis: pathophysiology and management

Faryal Mirza et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)

Article Endocrinology & Metabolism

Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score

Barbara C. Silva et al.

JOURNAL OF CLINICAL DENSITOMETRY (2015)

Article Clinical Neurology

Systematic Literature Review of Imaging Features of Spinal Degeneration in Asymptomatic Populations

W. Brinjikji et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2015)

Article Endocrinology & Metabolism

Utility of the trabecular bone score (TBS) in secondary osteoporosis

Fabio M. Ulivieri et al.

ENDOCRINE (2014)

Article Endocrinology & Metabolism

Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism

Cristina Eller-Vainicher et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)

Article Endocrinology & Metabolism

TBS (Trabecular Bone Score) and Diabetes-Related Fracture Risk

William D. Leslie et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Endocrinology & Metabolism

Identification of Rheumatoid Arthritis Patients With Vertebral Fractures Using Bone Mineral Density and Trabecular Bone Score

Sophie Breban et al.

JOURNAL OF CLINICAL DENSITOMETRY (2012)

Review Endocrinology & Metabolism

Alcohol and bone: review of dose effects and mechanisms

D. B. Maurel et al.

OSTEOPOROSIS INTERNATIONAL (2012)

Article Endocrinology & Metabolism

Bone Microarchitecture Assessed by TBS Predicts Osteoporotic Fractures Independent of Bone Density: The Manitoba Study

Didier Hans et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2011)

Article Endocrinology & Metabolism

WHO Absolute Fracture Risk Models (FRAX): Do Clinical Risk Factors Improve Fracture Prediction in Older Women Without Osteoporosis?

Teresa A. Hillier et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2011)

Article Endocrinology & Metabolism

Glucocorticoid-Induced Autophagy in Osteocytes

Xuechun Xia et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2010)

Review Endocrinology & Metabolism

The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis

T. P. van Staa

CALCIFIED TISSUE INTERNATIONAL (2006)